Acute Inflammatory Demyelinating Polyneuroradiculopathy with Ipilimumab in Metastatic Melanoma: A Case Report and Review of Literature

Ipilimumab (Bristol-Myers Squibb Co., New York, NY) is a novel anticancer medication used for the treatment of metastatic melanoma. The exact mechanism of its action remains unclear; however, data from previous clinical trials postulates the immunomodulatory activity of ipilimumab to enhance therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Rupareliya, Chintan, Naqvi, Syeda, Jani, Vishal B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498115/
https://www.ncbi.nlm.nih.gov/pubmed/28690944
http://dx.doi.org/10.7759/cureus.1310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498115/
https://www.ncbi.nlm.nih.gov/pubmed/28690944
http://dx.doi.org/10.7759/cureus.1310

Ejemplares similares